Kyriakos M.
- Country
- Germany
- Department
- Klinik und Poliklinik fur Kinder and Jugenmedizin
Research Overview
- A Phase III, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of N-Acetyl-L-Leucine in Patients with CACNA1A Disorders
- Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT)
- Phase III Randomized Double-Blind Crossover Study of N-Acetyl-L-Leucine in Niemann-Pick Disease Type C
Data & Insights
Has run more than one trial at 4 of 28 partner sites.
Specializations
Rare Neurological Disorders
This investigator specializes in the therapeutic management of Ataxia-Telangiectasia, a rare neurodegenerative condition affecting movement coordination and immune system function.
- Movement Disorders
- Neurodegeneration
- Ataxia Treatment
Focuses on innovative therapeutic approaches using compounds like N-Acetyl-L-Leucine for symptom management.
Lysosomal Storage Disorders
The investigator conducts research in Niemann-Pick disease type C, a rare genetic condition affecting lipid metabolism and cellular function.
- Metabolic Disorders
- Genetic Diseases
- Neurological Manifestations
Explores therapeutic interventions targeting neurological symptoms associated with lipid storage disorders.
Pediatric Neurological Conditions
Specializes in early intervention strategies for Tuberous Sclerosis Complex, focusing on developmental outcomes in young children.
- Early Intervention
- Neurodevelopmental Disorders
- Cognitive Development
Investigates preventive therapeutic approaches using mTOR inhibitors in early childhood.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.